₹ 14720 / 32 Shares Shares
Minimum Investment
₹438-460 per equity share
10 Dec 2025
12 Dec 2025
16
₹ 14720
₹438-460
17 Dec 2025
1,89,35,819 shares(aggregating up to ₹871.05 crore)
₹2 Per Equity Share
32 Shares
32 Shares
Nephrocare Health Services Ltd, incorporated in the year 2010, is an end-to-end dialysis care provider through its wide network of clinics across India and select international markets. It offers services such as diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy. As of March 31, 2025, Nephrocare operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal. This includes the world’s largest dialysis clinic in Uzbekistan. In India, the company had a presence across 269 cities in 21 States and four Union Territories. Approximately 76.73% of its clinics were located in tier II and tier III cities, addressing a critical need in underserved regions. In Fiscal 2025, Nephrocare treated 29,281 patients and performed more than 2.88 million dialysis treatments, amounting to approximately 10% of the country's total dialysis patient base. The number of dialysis machines operated by the company increased to 5,068 as of March 2025 from 4,714 in Fiscal 2024 and 3,662 in Fiscal 2023. Nephrocare has formulated strategic alliances with leading hospital chains like Max Super Speciality Hospital, Fortis Escorts Hospitals, Care Hospitals, Wockhardt Hospitals, Paras Healthcare, The Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers. As of March 2025, the workforce consisted of 3,230 employees, including both medical and administrative staff working across its clinics and corporate office.
2010
Vikram Vuppala
Nephrocare Health Services Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Retail (min) | ₹438-460 | ₹14,720 |
| Retail(max) | ₹438-460 | ₹1,91,360 |
| SHNI(min) | ₹438-460 | ₹2,06,080 |
| SHNI(max) | ₹438-460 | ₹9,86,240 |
| BHNI(min) | ₹438-460 | ₹10,00,960 |
Apply for all eligible candidates, Nephrocare Health Services Limited IPO.
Yes, clients receive consistent performance updates and guidance, ensuring investments remain aligned with goals at every stage.
NRIs can begin with as little as ₹1,000 per month depending on the investment vehicle, offering flexible entry points.
Not always. While some NFOs may perform well, they lack historical data. KSquare helps evaluate the potential.
Yes, mutual funds are subject to capital gains tax. Taxation depends on the type of fund and holding period.
Only ELSS funds have a 3-year lock-in. Other funds generally allow you to redeem anytime based on NAV.
Like regular funds, NFOs may involve expense ratios and entry/exit loads. KSquare discloses all costs transparently.
KSquare provides investment solutions, tax planning, mutual funds access, and portfolio management tailored specifically for NRIs.
The longer the duration, the better the returns. Ideally, stay invested for at least 5–10 years for best results.